Target intelligence / Profile preview

Nudix hydrolase 4 (NUDT4)

Target
NUDT4
Molecular classification
Enzyme
01

Overview

Nudix hydrolase 4 (NUDT4) is an enzyme that catalyzes the hydrolysis of the beta-phosphate from diphosphoinositol polyphosphates, such as diphosphoinositol pentakisphosphate (PP-InsP5) and diphosphoinositol tetrakisphosphate (PP-InsP4), which are high-energy signaling molecules involved in regulation of intracellular signaling and trafficking[1][5][6]. NUDT4 also acts on diadenosine polyphosphates (notably Ap6A and Ap5A) and can hydrolyze 5-phosphoribose 1-diphosphate, a glycolytic activator[1][5][6]. It is involved in pathways related to metabolic regulation, with proposed but not firmly established roles in cellular signaling cascades, and does not show major known disease associations or therapeutic interactions at present[1][3][6]. Multiple alternatively spliced isoforms exist, such as DIPP2alpha and DIPP2beta, but the main biochemical activity is hydrolysis of diphosphoinositol polyphosphates[1].

Other names
DIPP2DIPP2alphaDIPP2betaHDCMB47PKIAA0487Nudix (nucleoside diphosphate linked moiety X)-type motif 4Diphosphoinositol polyphosphate phosphohydrolase type 2Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 2Diphosphoinositol polyphosphate phosphohydrolase 2
02

Biological functions

Regulation of turnover of diphosphoinositol polyphosphatesIntracellular signalingCellular traffickingGeneration of glycolytic activators
03

Disease associations

Other (no evidence for major direct roles in cancer, inflammation, or neurodegenerative disease)

Beyond the preview

Go deeper on Nudix hydrolase 4 (NUDT4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nudix hydrolase 4 (NUDT4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call